Cargando…

Genomics driven precision oncology in advanced biliary tract cancer improves survival

BACKGROUND: Biliary tract cancers (BTCs) including intrahepatic, perihilar, and distal cholangiocarcinoma as well as gallbladder cancer, are rare but aggressive malignancies with few effective standard of care therapies. METHODS: We implemented integrative clinical sequencing of advanced BTC tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar-Sinha, Chandan, Vats, Pankaj, Tran, Nguyen, Robinson, Dan R., Gunchick, Valerie, Wu, Yi-Mi, Cao, Xuhong, Ning, Yu, Wang, Rui, Rabban, Erica, Bell, Janice, Shankar, Sunita, Mannan, Rahul, Zhang, Yuping, Zalupski, Mark M., Chinnaiyan, Arul M., Sahai, Vaibhav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245336/ https://www.ncbi.nlm.nih.gov/pubmed/37267699 http://dx.doi.org/10.1016/j.neo.2023.100910

Ejemplares similares

Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy
por: Gunchick, Valerie, et al.
Publicado: (2023)

Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
por: Mizrahi, Jonathan D, et al.
Publicado: (2020)

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
por: Cobain, Erin F., et al.
Publicado: (2021)

Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
por: Zhang, Yuping, et al.
Publicado: (2021)

An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
por: Shankar, Sunita, et al.
Publicado: (2020)

Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naïve Metastatic Pancreatic Cancer Patients
por: Owen, Sarah, et al.
Publicado: (2022)

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01
por: Sahai, Vaibhav, et al.
Publicado: (2022)

AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer
por: Tien, Jean Ching-Yi, et al.
Publicado: (2021)

Landscape of gene fusions in epithelial cancers: seq and ye shall find
por: Kumar-Sinha, Chandan, et al.
Publicado: (2015)

Integrative Clinical Genomics of Metastatic Cancer
por: Robinson, Dan R., et al.
Publicado: (2017)

Next‐generation sequencing in precision oncology: Patient understanding and expectations
por: Roberts, J. Scott, et al.
Publicado: (2019)

1 Analysis of dietary intake and biliary tract cancer risk in 638,860 Chinese and European adults in three cohort studies
por: Gunchick, Valerie, et al.
Publicado: (2023)

Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)

Clinical Profile of Pediatric Oncology Patients Treated by External Beam Radiotherapy: An Institutional Experience
por: Suhag, Virender, et al.
Publicado: (2017)

Transcriptome Sequencing to Detect Gene Fusions in Cancer
por: Maher, Christopher A., et al.
Publicado: (2009)

A Comparison of Single Molecule and Amplification Based Sequencing of Cancer Transcriptomes
por: Sam, Lee T., et al.
Publicado: (2011)

Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer
por: Rupp, Brittany, et al.
Publicado: (2022)

RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin()
por: Wei, Iris H., et al.
Publicado: (2014)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer
por: Bell, Hannah N., et al.
Publicado: (2022)

Profile of patients undergoing palliative radiotherapy: A single-institute study from a tertiary care oncology center
por: Suhag, Virender, et al.
Publicado: (2017)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
por: Dadhania, Vipulkumar, et al.
Publicado: (2022)

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)

Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy
por: Wilbur, H. Catherine, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series
por: Wang, Xiao-Ming, et al.
Publicado: (2021)

Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review
por: Connelly, James A., et al.
Publicado: (2018)

Metastatic prostate cancer diagnosed by fine‐needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates
por: Cantley, Richard L., et al.
Publicado: (2022)

Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study
por: Cackowski, Frank C., et al.
Publicado: (2020)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
por: Turkes, Fiona, et al.
Publicado: (2019)

Biochemical characterization of the interaction between KRAS and Argonaute 2
por: Waninger, Jessica J., et al.
Publicado: (2021)

Classification and Selection of Biomarkers in Genomic Data Using LASSO
por: Ghosh, Debashis, et al.
Publicado: (2005)

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine
por: Van Allen, Eliezer M., et al.
Publicado: (2016)

Argonaute 2 modulates EGFR–RAS signaling to promote mutant HRAS and NRAS-driven malignancies
por: Siebenaler, Ronald F, et al.
Publicado: (2022)

Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer
por: Robinson, Dan R., et al.
Publicado: (2011)

Biliary atresia
por: Sinha, C. K., et al.
Publicado: (2008)

Scoring systems for the management of oncological hepato-pancreato-biliary patients
por: Coombs, Alexander W., et al.
Publicado: (2022)

PubMed QUEST: The PubMed Query Search Tool. An informatics tool to aid cancer centers and cancer investigators in searching the PubMed databases
por: Hanauer, David A., et al.
Publicado: (2007)

BETting on a new prostate cancer treatment
por: Asangani, Irfan A, et al.
Publicado: (2014)

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato‐Biliary Oncology Group
por: Matsukuma, Satoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3uo449p1kuv26kpuf1uiu9f3va